you are being redirected to the website of our parent company, Schönherr Rechtsanwälte GmbH

healthcare & life sciences

Schoenherr's experts provide straight-to-the-point legal advice in all legal matters in the healthcare & life sciences industry.

Schoenherr's healthcare group draws on a breadth of experience across the firm's practice areas. We combine specialist knowledge and experience with the insights and track-record of our market-leading transactional practice.

Our healthcare & life sciences team covers a wide range of subjects, including pharmaceuticals, biochemistry, chemicals, e-health, cosmetics, medical devices, toys, tobacco products, food and feed.

Partners Andreas Natterer and Paweł Halwa lead and coordinate the Schoenherr expert team. We act for and advise all stakeholders active in the healthcare, life sciences, biotech and pharma sectors. Areas of particular expertise are regulatory life sciences work and transactional advice regarding targets in the healthcare and life sciences industry.

legal areas

Working closely and in integrated teams with specialists in:

our services

Our full-service offering in the healthcare & life sciences sector covers:

  • medicinal products
  • drugs, (narcotic) substances
  • food and feed
  • tobacco and tobacco substitutes
  • medical devices
  • genetically modified organisms
  • chemicals
  • cosmetics
  • medical and care institutions advice as well as hospitals

Our advisory covers inter alia:

  • transactional advice including m&a, banking & finance, capital markets as well as real estate (development)
  • advising on the establishment, operation and transfer of group practices, primary health care units and outpatient clinics
  • assisting strategic and financial investors in respect of the acquisition of outpatient clinics as well as out- and inpatient hospitals
  • m&a and other transactional advice in connection with investments in and the takeover of targets operating in the health care and life sciences industries
  • advising on the qualification and classification of software as medical devices, on telemedicine, e-health and e-medication
  • advising on contracts for clinical trials, quality agreements, licensing, collaboration, research and other agreements relevant to the sector
  • supporting medical device, pharmaceutical and medical supply manufacturers in relation to regulatory clearance proceedings, product marketing and distribution, and business compliance
  • providing guidance on the exploitation, enforcement and defence of ip rights
  • representing clients in medical malpractice claims
  • investigating corporate crimes, compliance violations, confidential information leaks and breach of legal duties
  • crisis management such as advising in product recalls on national and international levels
  • representation before national/European authorities/courts
back contact us





14 January 2021


C.Schmelz C.Holzer

VwGVG - Kommentar zum Verwaltungsgerichtsverfahrensgesetz


18 December 2020



Bulgaria: First legislative amendments introducing telemedicine/telehealth

On 16 December the Bulgarian Council of Ministers adopted a Decree amending the local Ordinance for exercising the right of access to medical care.


30 March 2020

austria vienna


The Police, Drones, and the Corona Pandemic – Reflections on Austria

The Corona pandemic is putting our world to an unexpected stress test. But despite all difficulties, in only a couple of weeks, people dramatically changed the way they work, shop, seek health care, and interact with each other. 


find all healthcare & life sciences news here


info corner

coronavirus info corner

The coronavirus presents us with completely new challenges. With the coronavirus info corner we aim to provide specifics about certain legal aspects surrounding Covid-19.

find out more



our team

Schoenherr's healthcare & life sciences team consists of experienced lawyers across all our CEE offices.